Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$7.80 USD
+0.88 (12.72%)
Updated Sep 29, 2023 04:00 PM ET
After-Market: $7.74 -0.06 (-0.77%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 38% (95 out of 247)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.31 | 1.35 | 9.99 |
Current Quarter Estimate | -0.64 | 7.43 | 55.00 |
Year Ago Quarter Estimate | -0.81 | 0.12 | 46.87 |
Next Quarter Estimate | -0.69 | 7.81 | 58.00 |
Next Year Estimate | -2.68 | 37.76 | 250.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 20.56 | 12.20 | 14.24 |
Next Year | -5.10 | 11.20 | 11.11 |
Last 5 Years | -379.20 | 11.30 | 9.00 |
Next 5 Years | 13.80 | 20.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 1.41 | 1.65 |
Price/Cash Flow (MRFY) | NA | 11.61 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -1,065.39% | -192.01% |
Return on Equity (TTM) | -55.14% | -57.29% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.